Find Research Outputs

Search results

• Article

  The effect of n-3 fatty acids and coenzyme Q10 supplementation on neutrophil leukotrienes, mediators of inflammation resolution and myeloperoxidase in chronic kidney disease

  Barden, A. E., Shinde, S., Burke, V., Puddey, I. B., Beilin, L. J., Irish, A. B., Watts, G. F. & Mori, T. A., 1 May 2018, In : Prostaglandins and Other Lipid Mediators. 136, p. 1-8 8 p.

  Research output: Contribution to journal › Article

  • coenzyme Q10
  • Inflammation Mediators
  • Leukotrienes
  • Omega-3 Fatty Acids
  • Peroxidase
  15 Citations (Scopus)

• The impact of non-vitamin K antagonist oral anticoagulants (NOACs) on anticoagulation therapy in rural Australia

  Bellinge, J. W., Paul, J. J., Walsh, L. S., Garg, L., Watts, G. F. & Schultz, C., 15 Jan 2018, In : The Medical journal of Australia. 208, 1, p. 18-23 6 p.

  Research output: Contribution to journal › Article

  Open Access

  • Anticoagulants
  • Atrial Flutter
  • Warfarin
  • Atrial Fibrillation
  • Western Australia
  6 Citations (Scopus)

• Under-Reporting of Family History of Premature Coronary Artery Disease in Patients Discharged From Coronary Care: Implications for the Detection of Familial Hypercholesterolaemia

  Goh, Y. A., Hansia, Z., Ellis, K. L., Pang, J., Hillis, G. S. & Watts, G. F., 26 Oct 2020, In : Heart, Lung & Circulation.

  Research output: Contribution to journal › Article

• Writing on the wall for precision medicine in the prevention of atherosclerotic cardiovascular disease

  Watts, G. F. & Stroes, E. S. G., 1 Dec 2018, In : Current Opinion in Lipidology. 29, 6, p. 433-435 3 p.

  Research output: Contribution to journal › Article
• Chapter

  Dyslipidemia

  Chan, D. T., Irish, A. B. & Watts, G. F., 1 Jan 2018, Handbook of Chronic Kidney Disease Management. 2nd ed. Kluwer Academic Publishers, p. 192-216 25 p.

  Research output: Chapter in Book/Conference paper › Chapter
• Comment/debate

  Correction: Effect of Lipoprotein (a) on the Diagnosis of Familial Hypercholesterolemia: Does It Make a Difference in the Clinic?

  Chan, D., Pang, J., Hooper, A., Bell, D., Burnett, J. & Watts, G., 26 Apr 2020, In : Clinical Chemistry. 66, 5, p. 737-738

  Research output: Contribution to journal › Comment/debate

• Lipoprotein(a): lodestar for future clinical trials

  Watts, G. F. & Boffa, M. B., 13 Oct 2018, In : The Lancet. 392, 10155, p. 1281-1282 2 p.

  Research output: Contribution to journal › Comment/debate
  6 Citations (Scopus)
• Editorial

  Atherogenic Dyslipoproteinemia and Management of ASCVD: Will New Indices Untie the Gordian Knot?

  Watts, G. F. & Chan, D. C., 5 May 2020, In : Journal of the American College of Cardiology. 75, 17, p. 2136-2139 4 p.

  Research output: Contribution to journal › Editorial
  1 Citation (Scopus)

• Editorial introductions (in Current Opinion in Lipidology)

  Stroes, E. S. G. & Watts, G. F., Dec 2018, In : Current Opinion in Lipidology. 29, 6, p. 433-433 1 p.

  Research output: Contribution to journal › Editorial

• Familial hypercholesterolaemia registry in the MENA region

  Kolovou, G. & Watts, G. F., 2020, In : Current Vascular Pharmacology. 18, 1, 1 p.

  Research output: Contribution to journal › Editorial

  Open Access

  • Hyperlipoproteinemia Type II
  • LDL Receptors
  • Registries
  • Mutation
  • Genes

• Improving the global care of familial hypercholesterolaemia: Starting the ball rolling

  Ray, K. K. & Watts, G. F., 1 Oct 2018, In : Atherosclerosis. 277, p. 230-233 4 p.

  Research output: Contribution to journal › Editorial
  4 Citations (Scopus)

• PCSK9 monoclonal antibody on a knife-edge: An article of faith in FH?

  Ward, N. C. & Watts, G. F., 1 Jul 2018, In : Journal of Clinical Lipidology. 12, 4, p. 844-848 5 p.

  Research output: Contribution to journal › Editorial

• Squaring up the health economics of PCSK9 monoclonal antibodies ‘down under’

  Watts, G. F. & Norman, R., 15 Sep 2018, In : International Journal of Cardiology. 267, p. 193-194 2 p.

  Research output: Contribution to journal › Editorial
  3 Citations (Scopus)

• Very special case of primary prevention with statins

  Pang, J., Martin, A. & Watts, G., 20 Apr 2020, In : Journal of Paediatric and Child Health. 56, 4, p. 656

  Research output: Contribution to journal › Editorial
• Letter

  Familial hypercholesterolaemia and COVID-19: triggering of increased sustained cardiovascular risk

  Vuorio, A., Watts, G. F. & Kovanen, P. T., 1 Jun 2020, In : Journal of Internal Medicine. 287, 6, p. 746-747 2 p.

  Research output: Contribution to journal › Letter

  Open Access
  16 Citations (Scopus)

• Familial Hypercholesterolemia in a Healthy Elderly Population

  Lacaze, P., Sebra, R., Riaz, M., Hooper, A. J., Tiller, J., Bakshi, A., Woods, R. L., Tonkin, A. M., Reid, C. M., Murray, A. M., Nicholls, S. J., Watts, G. F., Schadt, E. & McNeil, J. J., 1 Aug 2020, In : Circulation. Genomic and precision medicine. 13, 4, p. e002938

  Research output: Contribution to journal › Letter

• Patients with type 1 diabetes in a tertiary setting do not attain recommended lipid targets

  Lan, N. S. R., Yeap, B. B., Bell, D. A., Watts, G. F. & Fegan, P. G., Sep 2020, In : Diabetes and Metabolism. 46, 4, p. 339-341 3 p.

  Research output: Contribution to journal › Letter
• Review article

  A new approach to the diagnosis and treatment of atherosclerosis: the era of the liposome

  Kiaie, N., Gorabi, A. M., Penson, P. E., Watts, G., Johnston, T. P., Banach, M. & Sahebkar, A., Jan 2020, In : Drug Discovery Today. 25, 1, p. 58-72 15 p.

  Research output: Contribution to journal › Review article

  • Liposomes
  • Atherosclerosis
  • Cardiovascular Diseases
  • Angina Pectoris
  • Contrast Media
  3 Citations (Scopus)

• Effects of Allopurinol on Endothelial Function: A Systematic Review and Meta-Analysis of Randomized Placebo-Controlled Trials

  Cicero, A. F. G., Pirro, M., Watts, G. F., Mikhailidis, D. P., Banach, M. & Sahebkar, A., 1 Jan 2018, In : Drugs. 78, 1, p. 99-109 11 p.

  Research output: Contribution to journal › Review article

  • Allopurinol
  • Dilatation
  • Meta-Analysis
  • Systematic Reviews
  • Placebos
  19 Citations (Scopus)

• Familial hypercholesterolaemia: evolving knowledge for designing adaptive models of care

  Watts, G. F., Gidding, S. S., Mata, P., Pang, J., Sullivan, D. R., Yamashita, S., Raal, F. J., Santos, R. D. & Ray, K. K., 23 Jan 2020, In : Nature Reviews Cardiology.

  Research output: Contribution to journal › Review article

  • Hyperlipoproteinemia Type II
  • Ezetimibe
  • Blood Component Removal
  • Self-Help Groups
  • Precision Medicine
  8 Citations (Scopus)

• Familial hypercholesterolemia and elevated lipoprotein(a): double heritable risk and new therapeutic opportunities

  Vuorio, A., Watts, G. F., Schneider, W. J., Tsimikas, S. & Kovanen, P. T., 1 Jan 2020, In : Journal of Internal Medicine. 287, 1, p. 2-18 17 p.

  Research output: Contribution to journal › Review article

  Open Access

  • Hyperlipoproteinemia Type II
  • Lipoprotein(a)
  • LDL Lipoproteins
  • Therapeutics
  • Cholesterol
  14 Citations (Scopus)

• In search of the vulnerable patient or the vulnerable plaque: F-sodium fluoride positron emission tomography for cardiovascular risk stratification

  Bellinge, J. W., Francis, R. J., Majeed, K., Watts, G. F. & Schultz, C. J., 10 Jul 2018, In : Journal of Nuclear Cardiology. 25, 5, p. 1774-1783

  Research output: Contribution to journal › Review article

  • Sodium Fluoride
  • Positron-Emission Tomography
  • Cardiovascular Diseases
  • Vascular Calcification
  • Calcium
  13 Citations (Scopus)

• Is Lipoprotein(a) Ready for Prime-Time Use in the Clinic?

  Ellis, K. L. & Watts, G. F., 1 May 2018, In : Cardiology Clinics. 36, 2, p. 287-298 12 p.

  Research output: Contribution to journal › Review article

  • Lipoprotein(a)
  • Cardiovascular Diseases
  • Apoprotein(a)
  • Aortic Valve Stenosis
  • LDL Lipoproteins
  4 Citations (Scopus)

• Lipoprotein(a) and secondary prevention of atherothrombotic events: A critical appraisal

  Boffa, M. B., Stranges, S., Klar, N., Moriarty, P. M., Watts, G. F. & Koschinsky, M. L., 1 Nov 2018, In : Journal of Clinical Lipidology. 12, 6, p. 1358-1366 9 p.

  Research output: Contribution to journal › Review article

  • Lipoprotein(a)
  • Secondary Prevention
  • Preexisting Condition Coverage
  • Coronary Disease
  • Population
  16 Citations (Scopus)

• MicroRNAs: Novel Molecular Targets and Response Modulators of Statin Therapy

  Mohajeri, M., Banach, M., Atkin, S. L., Butler, A. E., Ruscica, M., Watts, G. F. & Sahebkar, A., 1 Nov 2018, In : Trends in Pharmacological Sciences. 39, 11, p. 967-981 15 p.

  Research output: Contribution to journal › Review article

  • Modulators
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • MicroRNAs
  • Lipid Metabolism
  • Proprotein Convertases
  29 Citations (Scopus)

• Nutraceuticals in the management of patients with statin-associated muscle symptoms, with a note on real-world experience

  Ward, N. C., Pang, J., Ryan, J. D. M. & Watts, G. F., 24 Jan 2018, In : Clinical Cardiology. 41, 1, p. 159-165

  Research output: Contribution to journal › Review article

  Open Access

  • Dietary Supplements
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • LDL Cholesterol
  • Muscles
  • Cardiovascular Diseases
  10 Citations (Scopus)

• PCSK9 in context: A contemporary review of an important biological target for the prevention and treatment of atherosclerotic cardiovascular disease

  Page, M. M. & Watts, G. F., 1 Feb 2018, In : Diabetes, Obesity and Metabolism. 20, 2, p. 270-282 13 p.

  Research output: Contribution to journal › Review article

  • Proprotein Convertase 9
  • Cardiovascular Diseases
  • Monoclonal Antibodies
  • ALN-PCS
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  17 Citations (Scopus)

• Quantifying atherogenic lipoproteins for lipid-lowering strategies: Consensus-based recommendations from EAS and EFLM

  for the European Atherosclerosis Society (EAS) and the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) Joint Consensus Initiative, Feb 2020, In : Atherosclerosis. 294, p. 46-61 16 p.

  Research output: Contribution to journal › Review article

  Open Access

  • Lipoproteins
  • LDL Cholesterol
  • Atherosclerosis
  • Lipids
  • Cholesterol
  13 Citations (Scopus)

• Quantifying atherogenic lipoproteins for lipid-lowering strategies: Consensus-based recommendations from EAS and EFLM

  Langlois, M. R., Nordestgaard, B. G., Langsted, A., Chapman, M. J., Aakre, K. M., Baum, H., Borén, J., Bruckert, E., Catapano, A., Cobbaert, C., Collinson, P., Descamps, O. S., Duff, C. J., Von Eckardstein, A., Hammerer-Lercher, A., Kamstrup, P. R., Kolovou, G., Kronenberg, F., Mora, S., Pulkki, K. & 9 others, Remaley, A. T., Rifai, N., Ros, E., Stankovic, S., Stavljenic-Rukavina, A., Sypniewska, G., Watts, G. F., Wiklund, O. & Laitinen, P., 1 Apr 2020, In : Clinical Chemistry and Laboratory Medicine. 58, 4, p. 496-517 22 p.

  Research output: Contribution to journal › Review article

  Open Access

  • Lipoproteins
  • LDL Cholesterol
  • lipoprotein cholesterol
  • Atherosclerosis
  • Lipids
  13 Citations (Scopus)

• Screening for familial hypercholesterolaemia in primary care: Time for general practice to play its part

  Brett, T., Qureshi, N., Gidding, S. & Watts, G. F., 1 Oct 2018, In : Atherosclerosis. 277, p. 399-406 8 p.

  Research output: Contribution to journal › Review article

  • Hyperlipoproteinemia Type II
  • General Practice
  • Primary Health Care
  • Information Technology
  • Electronic Health Records
  9 Citations (Scopus)

• The brave new world of genetic testing in the management of the dyslipidaemias

  Nawawi, H. M., Chua, Y. A. & Watts, G. F., 2020, In : Current Opinion in Cardiology. 35, 3, p. 226-233 8 p.

  Research output: Contribution to journal › Review article

  • Genetic Testing
  • Dyslipidemias
  • Familial Combined Hyperlipidemia
  • Hyperlipoproteinemia Type II
  • Familial HDL deficiency
  1 Citation (Scopus)

• The Knowns and Unknowns of Contemporary Statin Therapy for Familial Hypercholesterolemia

  Pang, J., Chan, D. C. & Watts, G. F., Nov 2020, In : Current Atherosclerosis Reports. 22, 11, 64.

  Research output: Contribution to journal › Review article

  • Hyperlipoproteinemia Type II
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Therapeutics
  • Cardiovascular Diseases
  • LDL Cholesterol
  2 Citations (Scopus)

• The Present and the Future of Genetic Testing in Familial Hypercholesterolemia: Opportunities and Caveats

  Hooper, A. J., Burnett, J. R., Bell, D. A. & Watts, G. F., 1 Jun 2018, In : Current Atherosclerosis Reports. 20, 6, 31.

  Research output: Contribution to journal › Review article

  • Hyperlipoproteinemia Type II
  • Genetic Testing
  • High-Throughput Nucleotide Sequencing
  • Genomics
  • oxidized low density lipoprotein
  9 Citations (Scopus)

• The Role of Nutraceuticals in Statin Intolerant Patients

  International Lipid Expert Panel (ILEP), 3 Jul 2018, In : Journal of the American College of Cardiology. 72, 1, p. 96-118 23 p.

  Research output: Contribution to journal › Review article

  • Dietary Supplements
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • red yeast rice
  • Cynara scolymus
  • Cardiovascular Diseases
  81 Citations (Scopus)